EG23547A - Preparation of a topical pharmaceutical preparation of curcumin alone or a combination of circumin plus capsaicin as an effective remedy for treatmentof peripheral neuropathies - Google Patents

Preparation of a topical pharmaceutical preparation of curcumin alone or a combination of circumin plus capsaicin as an effective remedy for treatmentof peripheral neuropathies

Info

Publication number
EG23547A
EG23547A EG2002111270A EG2002111270A EG23547A EG 23547 A EG23547 A EG 23547A EG 2002111270 A EG2002111270 A EG 2002111270A EG 2002111270 A EG2002111270 A EG 2002111270A EG 23547 A EG23547 A EG 23547A
Authority
EG
Egypt
Prior art keywords
preparation
circumin
treatmentof
combination
topical pharmaceutical
Prior art date
Application number
EG2002111270A
Inventor
Mallah Ahmed Ibrahim Mohame El
Original Assignee
Mallah Ahmed Ibrahim Mohame El
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallah Ahmed Ibrahim Mohame El filed Critical Mallah Ahmed Ibrahim Mohame El
Priority to EG2002111270A priority Critical patent/EG23547A/en
Priority to AU2003285281A priority patent/AU2003285281A1/en
Priority to PCT/EG2003/000011 priority patent/WO2004047717A2/en
Application granted granted Critical
Publication of EG23547A publication Critical patent/EG23547A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
EG2002111270A 2002-11-25 2002-11-25 Preparation of a topical pharmaceutical preparation of curcumin alone or a combination of circumin plus capsaicin as an effective remedy for treatmentof peripheral neuropathies EG23547A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EG2002111270A EG23547A (en) 2002-11-25 2002-11-25 Preparation of a topical pharmaceutical preparation of curcumin alone or a combination of circumin plus capsaicin as an effective remedy for treatmentof peripheral neuropathies
AU2003285281A AU2003285281A1 (en) 2002-11-25 2003-11-23 Topical application of curcumin for the treatment of peripheral neuropathy
PCT/EG2003/000011 WO2004047717A2 (en) 2002-11-25 2003-11-23 Topical application of curcumin for the treatment of peripheral neuropathy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EG2002111270A EG23547A (en) 2002-11-25 2002-11-25 Preparation of a topical pharmaceutical preparation of curcumin alone or a combination of circumin plus capsaicin as an effective remedy for treatmentof peripheral neuropathies

Publications (1)

Publication Number Publication Date
EG23547A true EG23547A (en) 2006-05-10

Family

ID=32946815

Family Applications (1)

Application Number Title Priority Date Filing Date
EG2002111270A EG23547A (en) 2002-11-25 2002-11-25 Preparation of a topical pharmaceutical preparation of curcumin alone or a combination of circumin plus capsaicin as an effective remedy for treatmentof peripheral neuropathies

Country Status (3)

Country Link
AU (1) AU2003285281A1 (en)
EG (1) EG23547A (en)
WO (1) WO2004047717A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9393198B2 (en) 2010-03-22 2016-07-19 Signpath Pharma Inc. Intravenous curcumin and derivatives for treatment of neurodegenerative and stress disorders
EP2685963A4 (en) * 2011-03-16 2014-11-19 Signpath Pharma Inc Curcumin combination with anti-type 2 diabetic drugs for prevention and treatment of disease sequelae, drug-related adverse reactions, and improved glycemic control
US10117881B2 (en) 2011-06-03 2018-11-06 Signpath Pharma, Inc. Protective effect of DMPC, DMPG, DMPC/DMPG, LYSOPG and LYSOPC against drugs that cause channelopathies
US8753674B2 (en) 2011-06-03 2014-06-17 Signpath Pharma Inc. Liposomal mitigation of drug-induced long QT syndrome and potassium delayed-rectifier current
US10349884B2 (en) 2011-06-03 2019-07-16 Sighpath Pharma Inc. Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel
US10449193B2 (en) 2011-06-03 2019-10-22 Signpath Pharma Inc. Protective effect of DMPC, DMPG, DMPC/DMPG, lysoPG and lysoPC against drugs that cause channelopathies
US10238602B2 (en) 2011-06-03 2019-03-26 Signpath Pharma, Inc. Protective effect of DMPC, DMPG, DMPC/DMPG, LysoPG and LysoPC against drugs that cause channelopathies
WO2014036534A1 (en) 2012-08-31 2014-03-06 University Of North Texas Health Science Center Curcumin-er, a liposomal-plga sustained release nanocurcumin for minimizing qt prolongation for cancer therapy
CA2933204C (en) 2013-12-18 2020-04-28 Signpath Pharma, Inc. Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel
PL3277273T3 (en) * 2015-03-31 2020-11-02 Kolinpharma S.P.A. A composition for the treatment of neuropathies and/or neuropathic pain
WO2016174599A1 (en) 2015-04-27 2016-11-03 Omniactive Health Technologies Limited Capsicum compositions and uses thereof
US11806401B2 (en) 2016-04-27 2023-11-07 Signpath Pharma, Inc. Prevention of drug-induced atrio-ventricular block
IT201700088621A1 (en) * 2017-08-01 2019-02-01 Inpha Duemila Srl Food supplements for use in the treatment of diseases associated with alterations of peripheral nerve trophism.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11246398A (en) * 1998-03-02 1999-09-14 Kyowa Hakko Kogyo Co Ltd Prophylactic or therapeutic agent for disorder caused by increment of lipoperoxide in vivo
JPH11246399A (en) * 1998-03-03 1999-09-14 Lion Corp Lipid metabolism improving composition

Also Published As

Publication number Publication date
AU2003285281A1 (en) 2004-06-18
AU2003285281A8 (en) 2004-06-18
WO2004047717A2 (en) 2004-06-10
WO2004047717A3 (en) 2004-09-23

Similar Documents

Publication Publication Date Title
CY2015003I1 (en) PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF CANCER
TWI346558B (en) Pharmaceutical composition for chronic treatment of inflammation and use thereof
IL213806A0 (en) Use of derivatives of n-phenylpiperazin-1-yl-acetamide for the preparation of a pharmaceutical compositions for treatment of diabetes related conditions
TWI345979B (en) Topical pharmaceutical compositions for the treatment of dermatitis
ZA200703601B (en) Medicaments for the treatment or prevention of fibriotic diseases
PT1362582E (en) Enrobed solid dosage form
IL216931A0 (en) Pharmaceutical formulation that comprisies azelastine and fluticasone and aproduct comprising these as antihistamine and anti - inflammatory agent
IL177914A0 (en) Use of indazolecarboxamide derivatives for the preparation of a medicament that is intended for the treatment and prevention of paludism
EP1689412A4 (en) Vitamin d analogs for obesity prevention and treatment
AU2003299826A1 (en) Pharmaceutical safety dosage forms
HUP0303313D0 (en) Transdermal pharmaceutical compositions
ZA200410229B (en) Administration of therapeutic viruses
EG23547A (en) Preparation of a topical pharmaceutical preparation of curcumin alone or a combination of circumin plus capsaicin as an effective remedy for treatmentof peripheral neuropathies
EP1648474A4 (en) Methods and pharmaceutical compositions for healing wounds
IL173148A0 (en) Methods and pharmaceutical compositions for healing wounds
AU2003276572A1 (en) Pharmaceutical dosage forms of biguanide-sulfonylurea combinations
AU2002323823A1 (en) Medicament for prevention and treatment of fracture and osteoporosis
HK1111599A1 (en) Pharmaceutical compositions for the treatment of cellulite
HU0302441D0 (en) Pharmaceutical compositions having antibiothic effect
IL149377A0 (en) Pharmaceutical formulation comprising melatonin
AU2003211610A1 (en) Pharmaceutical compositions for the treatment or prevention of osteoporosis
PT1849468E (en) Pharmaceutical composition comprising roflumilast and levocetirizine
SI1562577T1 (en) Acetyl-l-carnitine for the prevention and/or treatment of peripheral neuropathies induced by thalidomide
IL164470A (en) Pharmaceutical composition comprising arsenite for the treatment of solid malignancies
EP1551456A4 (en) Pharmaceutical composition for prevention and treatment of kidney diseases